Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Boudou-Rouquette

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
International Orthopaedics|July 27, 2018
Higher complications after previous external beam radiation for extremity soft-tissue sarcoma in the surgical treatment of a local recurrence: a comparative retrospective study of one hundred and three patientsGauthier Eloy, Caroline Daveau, Sarah Kreps, et al.
Anti-Cancer Drugs|February 15, 2012
Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcomaOlivier Mir, Pascaline Boudou-Rouquette, Frédérique Larousserie, et al.
Virchows Archiv : an International Journal of Pathology|March 2, 2010
Imprint cytology in tumor tissue bank quality control: an efficient method to evaluate tumor necrosis and to detect samples without tumor cellsPascaline Boudou-Rouquette, Noura Touibi, Pierre-Yves Boëlle, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Drug interactions with solid tumour-targeted therapiesAudrey Thomas-Schoemann, Benoit Blanchet, Christophe Bardin, et al.
Targeted Oncology|November 18, 2011
Posterior reversible encephalopathy syndrome induced by anti-VEGF agentsCamille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Oncology|October 19, 2012
Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosisMarion Dhooge, Romain Coriat, Olivier Mir, et al.
Bulletin Du Cancer|November 19, 2017
[Geriatric assessment and prognostic scores in older cancer patient: Additional support to the therapeutic decision?]Frédéric Pamoukdjian, Evelyne Liuu, Philippe Caillet, et al.
Nutrition and Cancer|October 9, 2013
Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancerAnatole Cessot, Romain Coriat, Oliver Mir, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2013
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS)Emilie Hénin, Benoit Blanchet, Pascaline Boudou-Rouquette, et al.
BMC Palliative Care|March 14, 2020
First referral to an integrated onco-palliative care program: a retrospective analysis of its timingClaire Barth, Isabelle Colombet, Vincent Montheil, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
International Orthopaedics|July 27, 2018
Higher complications after previous external beam radiation for extremity soft-tissue sarcoma in the surgical treatment of a local recurrence: a comparative retrospective study of one hundred and three patientsGauthier Eloy, Caroline Daveau, Sarah Kreps, et al.
Anti-Cancer Drugs|February 15, 2012
Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcomaOlivier Mir, Pascaline Boudou-Rouquette, Frédérique Larousserie, et al.
Virchows Archiv : an International Journal of Pathology|March 2, 2010
Imprint cytology in tumor tissue bank quality control: an efficient method to evaluate tumor necrosis and to detect samples without tumor cellsPascaline Boudou-Rouquette, Noura Touibi, Pierre-Yves Boëlle, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Drug interactions with solid tumour-targeted therapiesAudrey Thomas-Schoemann, Benoit Blanchet, Christophe Bardin, et al.
Targeted Oncology|November 18, 2011
Posterior reversible encephalopathy syndrome induced by anti-VEGF agentsCamille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Oncology|October 19, 2012
Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosisMarion Dhooge, Romain Coriat, Olivier Mir, et al.
Bulletin Du Cancer|November 19, 2017
[Geriatric assessment and prognostic scores in older cancer patient: Additional support to the therapeutic decision?]Frédéric Pamoukdjian, Evelyne Liuu, Philippe Caillet, et al.
Nutrition and Cancer|October 9, 2013
Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancerAnatole Cessot, Romain Coriat, Oliver Mir, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2013
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS)Emilie Hénin, Benoit Blanchet, Pascaline Boudou-Rouquette, et al.
BMC Palliative Care|March 14, 2020
First referral to an integrated onco-palliative care program: a retrospective analysis of its timingClaire Barth, Isabelle Colombet, Vincent Montheil, et al.
Pageof 13